Showing results (31-40 of 201) with videos related to
Sort By:
Pageof 21
Immunity & Inflammation|February 11, 2026
NF-κB: master regulator of cellular responses in health and diseaseAlexander Hoffmann, Genhong Cheng, David BaltimoreNature Reviews. Immunology|August 1, 2019
Alternative mRNA splicing in cancer immunotherapyLuke Frankiw, David Baltimore, Guideng LiThe EMBO Journal|October 9, 2003
Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificitiesAlexander Hoffmann, Thomas H Leung, David BaltimoreTrends in Immunology|March 16, 2019
The Cellular Immunotherapy Revolution: Arming the Immune System for Precision TherapyRichard D Paucek, David Baltimore, Guideng LiCell|August 19, 2004
One nucleotide in a kappaB site can determine cofactor specificity for NF-kappaB dimersThomas H Leung, Alexander Hoffmann, David BaltimoreCell|January 14, 2017
30 Years of NF-κB: A Blossoming of Relevance to Human PathobiologyQian Zhang, Michael J Lenardo, David BaltimorePlos One|July 30, 2011
A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidaseJesse D Bloom, Jagannath S Nayak, David BaltimoreScience (New York, N.Y.)|June 5, 2010
Permissive secondary mutations enable the evolution of influenza oseltamivir resistanceJesse D Bloom, Lizhi Ian Gong, David BaltimoreImmunity|February 20, 2007
MicroRNAs and immunity: tiny players in a big fieldKonstantin D Taganov, Mark P Boldin, David BaltimoreProceedings of the National Academy of Sciences of the United States of America|July 26, 2006
Targeting lentiviral vectors to specific cell types in vivoLili Yang, Leslie Bailey, David Baltimore, et al.Pageof 21